JP

Jason Park

Founder of Empress Therapeutics

Cambridge, Massachusetts

Overview 

Jason Park is a highly accomplished Scientist, Founder, and CEO at Empress Tx in Cambridge, Massachusetts. With a Ph.D. from Yale University and experience as a Project Leader at The Boston Consulting Group, he has successfully co-founded Empress Therapeutics and led strategic initiatives in the biotechnology sector. Park's career highlights include founding Empress Therapeutics and serving as a Partner at Flagship Pioneering, showcasing his expertise in entrepreneurship and corporate development within the life sciences industry.

Work Experience 

  • CEO & Co-Founder

    2022 - Current

    Using the power of genetics & evolution to generate safe, effective, easy-to-administer (small molecule) medicines.

Empress Therapeutics is to generate transformative drug candidates that get to the clinic faster and cheaper.

Raised $50,000,000.00 from Flagship Pioneering.

  • Partner

    2015

    Scientist, founder, and entrepreneur creating pioneering life science companies. CEO & Co-Founder, Empress Therapeutics. COO & Co-Founder, Sonata Therapeutics.

Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.

  • Project Leader

    2011 - 2015

    Core member of Healthcare, Technology, and Strategy practice areas as well as BCG's Scientist Network. Served out of New York, Mumbai, and Paris offices and led projects across a broad variety of topics, including early stage R&D, portfolio investment strategy, biopharmaceutical manufacturing, strategic and commercial due diligence, and global health.

BCG Securities focuses on wealth management with high net worth individuals.

  • Associate Director

    2006 - 2008

    Biotech company focused on the development of nanoscale therapeutic and diagnostic drug delivery agents

  • Co-founder

    2006 - 2008

Articles About Jason

Relevant Websites